Shares of TherapeuticsMD (TXMD) jumped 6% to $1.06 at 16:22 EST on Wednesday, following the last session’s upward trend. NASDAQ Composite (TXMD) is rising 0.92% to $14,631.95, following the last session’s upward trend. This seems, so far, a somewhat up trend exchanging session today.
TherapeuticsMD’s last close was $1.00, 63.64% below its 52-week high of $2.75.
Today’s last reported volume for TherapeuticsMD is 3791104 which is 41.26% below its average volume of 6454552.
The company’s growth estimates for the present quarter and the next is 42.1% and 25%, respectively.
Year-on-year quarterly revenue growth grew by 62.2%, now sitting on 72.49M for the twelve trailing months.
TherapeuticsMD’s last week, last month’s, and last quarter’s current volatility was a negative 1.70%, a negative 1.41%, and a positive 3.62%, respectively.
TherapeuticsMD’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.36% (last week), 3.22% (last month), and 3.62% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TherapeuticsMD’s stock is considered to be overbought (>=80).
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $1.06 at 16:22 EST, way below its 52-week high of $2.75 and higher than its 52-week low of $0.98.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is way below its 50-day moving average of $1.19 and way under its 200-day moving average of $1.36.
More news about TherapeuticsMD (TXMD).